Article
Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
British journal of cancer - 1 Nov 2004
Ottey M, Han S-Y, Druck T, Barnoski B L, McCorkell K A, Croce C M, Raventos-Suarez C, Fairchild C R, Wang Y, Huebner K
Abstract excerpt
To identify functions of the fragile tumour suppressor gene, FHIT, matched pairs of Fhit-negative and -positive human cancer cell clones, and normal cell lines established from Fhit -/- and +/+ mice, were stressed and examined for differences in cell cycle kinetics and survival. A larger fraction of Fhit-negative human cancer cells and murine kidney cells survived treatment with mitomycin C or UVC light compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
